Search

everythinglearnresearchcommunity

for

Search:↓

Both injectable contraceptives lower testosterone and SHBG levels, with NET-EN having a greater effect than DMPA-IM.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Steroid sulfatase inhibitors could potentially treat hormone-related disorders like certain cancers, hair loss, acne, and improve cognitive dysfunction.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Some dibenzo compounds might help treat cancer with fewer side effects.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Cyproterone acetate effectively treats virilized women, especially under 35, despite some side effects.

17α-estradiol lotion can reduce hair loss but doesn't promote new hair growth.

Cyproterone acetate combined with ethinyl estradiol significantly reduced hirsutism in women.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Oestrogen does not affect adrenal androgen levels in children and adolescents.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Tamoxifen caused hair loss in a 52-year-old woman.

5-Alpha-Reductase Inhibitors can cause negative side effects.

The patient was satisfied with hormone therapy, and her epilepsy remained stable.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Antiandrogenic treatments can effectively manage certain skin conditions by using female hormones.

Localized estrogen treatments may improve skin quality with fewer risks than systemic hormone therapy.

The document concludes that antiandrogenic drugs like cyproterone acetate and spironolactone are effective but not permanent treatments for skin-related androgenization in women.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Rare ovarian tumors can cause increased male hormones in postmenopausal women; surgery is an effective treatment.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

The document concludes that women should not use 5-alpha-reductase inhibitors due to the risk of birth defects and limited effectiveness.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

17β-Estradiol slows wound healing in male mice through estrogen receptor-α.